Elevated Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$663K Sell
1,594
-1,036
-39% -$384K 0.18% 102
2026
Q1
$712K Sell
2,630
-1,216
-32% -$362K 0.18% 137
2025
Q4
$1.27M Buy
3,846
+1,191
+45% +$404K 0.3% 84
2025
Q3
$917K Buy
2,655
+1,469
+124% +$444K 0.23% 114
2025
Q2
$621K Hold
1,186
0.17% 165
2025
Q1
$621K Buy
1,186
+35
+3% +$17.9K 0.17% 165
2024
Q4
$582K Buy
1,151
+350
+44% +$199K 0.16% 179
2024
Q3
$469K Buy
+801
New +$453K 0.12% 212
2019
Q4
$276K Buy
+939
New +$246K 0.31% 89
2019
Q1
$632K Buy
+2,245
New +$573K 0.42% 86

Other funds holding UNH

Elevated Capital Advisors's UNH Position: Q2 2026 in Review

Elevated Capital Advisors reduced its UnitedHealth (UNH) stake by 39% in Q2 2026, selling an estimated $384K and leaving 1,594 shares worth $663K. The position accounts for 0.18% of the portfolio, ranked #102.

Elevated Capital Advisors first reported a position in UNH in Q1 2019 and has held it in 10 quarters since. The position peaked at $1.27M in Q4 2025. 1,855 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Elevated Capital Advisors held 1,594 shares of UnitedHealth worth $663K as of Q2 2026.
  • Elevated Capital Advisors sold 1,036 UnitedHealth shares in Q2 2026, an estimated $384K.
  • UnitedHealth made up 0.18% of Elevated Capital Advisors's portfolio in Q2 2026, its #102 holding.
  • Elevated Capital Advisors first reported a position in UnitedHealth in Q1 2019 and has held it in 10 quarters since.
  • Elevated Capital Advisors's UnitedHealth position peaked at $1.27M in Q4 2025.
  • 1,855 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.